Search research articles
Contact Us
Filters
Showing results (211-220 of 304) with videos related to
Page
of 31
Sort By:
Clinical Lung Cancer
|
May 26, 2021
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
Lauren Averett Byers, Alejandro Navarro, Eric Schaefer, et al.
Chemosphere
|
October 8, 2013
Stability of solid-phase selenium species in fly ash after prolonged submersion in a natural river system
Mark A Chappell, Jennifer M Seiter, Anthony J Bednar, et al.
Acta Crystallographica. Section D, Structural Biology
|
September 25, 2023
Increasing the bulk of the 1TEL-target linker and retaining the 10×His tag in a 1TEL-CMG2-vWa construct improves crystal order and diffraction limits
Parag L Gajjar, Maria J Pedroza Romo, Celeste M Litchfield, et al.
Physical Review Letters
|
April 15, 1991
Asymmetry measurement of pion elastic scattering from polarized 13C in the energy region of the P33 resonance
Yen, Brinkmöller, Dehnhard, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Decreasing the flexibility of the TELSAM-target protein linker and omitting the cleavable fusion tag improves crystal order and diffraction limits
Parag L Gajjar, Maria J Pedroza Romo, Celeste M Litchfield, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 3, 2010
Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence
Meera Nanjundan, Lauren Averett Byers, Mark S Carey, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1997
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity
S M Daluge, S S Good, M B Faletto, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Physical Review. C, Nuclear Physics
|
August 1, 1994
Pion elastic scattering from polarized 13C in the energy region of the P33 resonance
Yen, Brinkmöller, Dehnhard, et al.
Cancer Research
|
January 24, 2020
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer
Sandra Cristea, Garry L Coles, Daniel Hornburg, et al.
Page
of 31
Search research articles
Search
Showing results (211-220 of 304) with videos related to
Sort By:
Page
of 31
Clinical Lung Cancer
|
May 26, 2021
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
Lauren Averett Byers, Alejandro Navarro, Eric Schaefer, et al.
Chemosphere
|
October 8, 2013
Stability of solid-phase selenium species in fly ash after prolonged submersion in a natural river system
Mark A Chappell, Jennifer M Seiter, Anthony J Bednar, et al.
Acta Crystallographica. Section D, Structural Biology
|
September 25, 2023
Increasing the bulk of the 1TEL-target linker and retaining the 10×His tag in a 1TEL-CMG2-vWa construct improves crystal order and diffraction limits
Parag L Gajjar, Maria J Pedroza Romo, Celeste M Litchfield, et al.
Physical Review Letters
|
April 15, 1991
Asymmetry measurement of pion elastic scattering from polarized 13C in the energy region of the P33 resonance
Yen, Brinkmöller, Dehnhard, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Decreasing the flexibility of the TELSAM-target protein linker and omitting the cleavable fusion tag improves crystal order and diffraction limits
Parag L Gajjar, Maria J Pedroza Romo, Celeste M Litchfield, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 3, 2010
Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence
Meera Nanjundan, Lauren Averett Byers, Mark S Carey, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1997
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity
S M Daluge, S S Good, M B Faletto, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Physical Review. C, Nuclear Physics
|
August 1, 1994
Pion elastic scattering from polarized 13C in the energy region of the P33 resonance
Yen, Brinkmöller, Dehnhard, et al.
Cancer Research
|
January 24, 2020
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer
Sandra Cristea, Garry L Coles, Daniel Hornburg, et al.
Page
of 31